Entry |
|
Name |
Edrophonium chloride (JP18/USP/INN); Enlon (TN); Tensilon (TN) |
Formula |
C10H16NO. Cl
|
Exact mass |
201.092
|
Mol weight |
201.6931
|
Structure |
|
Simcomp |
|
Class |
Neuropsychiatric agent
DG01595 Cholinesterase inhibitor
DG01593 Acetylcholinesterase inhibitor
|
Remark |
Therapeutic category: | 7229 |
|
Efficacy |
Antidote (to curare principles), Diagnostic aid (myasthenia gravis) |
Disease |
Myasthenia gravis (emergency treatment) [DS: H01594] |
Comment |
Reversible cholinesterase inhibitor
|
Target |
|
Pathway |
|
Interaction |
|
Structure map |
map07220 | Cholinergic and anticholinergic drugs |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
V VARIOUS
V04 DIAGNOSTIC AGENTS
V04C OTHER DIAGNOSTIC AGENTS
V04CX Other diagnostic agents
V04CX07 Edrophonium
D00994 Edrophonium chloride (JP18/USP/INN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
7 Agents not mainly for therapeutic purpose
72 Intracorporeal diagnostic agents
722 Various function testing reagents
7229 Others
D00994 Edrophonium chloride (JP18/USP/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01595 Cholinesterase inhibitor
DG01593 Acetylcholinesterase inhibitor
D00994 Edrophonium chloride
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Carboxylic-ester hydrolases
ACHE
D00994 Edrophonium chloride (JP18/USP/INN) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00994 Edrophonium chloride
D00994 Edrophonium chloride injection
|
Other DBs |
|
KCF data |
ATOM 13
1 X Cl 26.0173 -22.4203 #-
2 C8y C 19.6834 -21.6392
3 C8x C 19.6834 -23.0409
4 C8x C 20.8974 -23.7418
5 C8x C 22.1114 -23.0409
6 C8y C 22.1114 -21.6392
7 C8x C 20.8974 -20.9383
8 O1a O 18.4695 -20.9383
9 N1d N 23.3441 -20.9272 #+
10 C1b C 24.5509 -21.6238
11 C1a C 25.7348 -20.9402
12 C1a C 23.3441 -19.5254
13 C1a C 23.3441 -22.3290
BOND 12
1 2 3 1
2 3 4 2
3 4 5 1
4 5 6 2
5 6 7 1
6 2 7 2
7 2 8 1
8 6 9 1
9 9 10 1
10 10 11 1
11 9 12 1
12 9 13 1
|